Explore new findings on drug-resistant breast cancer and how targeting cell cycle regulators may improve treatment outcomes.
News-Medical.Net on MSN
Study identifies a powerful strategy to overcome drug resistance in breast cancer
A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Communications , identifies a powerful strategy to overcome drug resistance in ...
Combination therapies represent a promising frontier in cancer treatment, addressing the critical need to enhance efficacy while minimizing resistance. By combining different therapeutic agents and ...
Drug resistance has long turned some of the most advanced lung cancer therapies into temporary victories, with tumors learning to shrug off chemotherapy that once held them in check. A new wave of ...
Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites seeding new resistant tumors elsewhere in the body. Combating the problem has ...
Ovarian cancer treatment faces challenges with high relapse and drug resistance rates, despite initial chemotherapy effectiveness. Cytokines like IL-6 and IL-11 are associated with complex tumor ...
File photo: — Patient Receives Chemotherapy. Source - National Cancer Institute/ Rhoda Baer (Photographer). Public Domain — CC0 1.0 Universal File photo: — Patient Receives Chemotherapy. Source - ...
In a recent study published in the journal Scientific Reports, a group of researchers tested the anticancer efficacy, mechanisms, and combinatorial value of pacificusoside C (PaC) and cucumariosides ...
TARPON SPRINGS, Fla., April 25, 2025 -- Allarity Therapeutics, Inc. (ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results